DG Comp official: invisible hand isn’t working in pharma

Pallavi Guniganti

03 June 2019

DG Comp official: invisible hand isn’t working in pharma

Paul Csiszár at GCR Live

Pharmaceutical investment incentives are better fueled by longer patent periods than by governments allowing drugmakers to block entry or charge excessive prices, a director at the European Commission’s Directorate-General for Competition has said.